APT 2025 Committees
| Presiding Chair | Jodi Goodwin, Takeda |
| Presiding Chair-Elect | Darcey Clark, Merck |
Discovery
| Chair | Jodi Goodwin, Takeda |
| Chair-Elect | Darcey Clark, Merck |
|
Jonathan Heyen, Treeline Bio Prathap Kumar Mahalingaiah, AstraZeneca Jon Maher, Pliant Therapeutics Rama Pai, Merck Helen Yu, Vertex Yoav Timsit, Novartis Connie Wu, Genentech |
Development
| Chair | Betty Pettersen, Alexion |
| Chair-Elect | Yuan Lu, CinRx Pharma |
|
Joe Cichocki, Vertex Pia Kasperkovitz, Bright Peak Therapeutics Ed Dere, Genentech Birgit Fogal, Boehringer Ingelheim Radha Sura, Gilead Christine Mollica, Amgen Michael Santostefano, Merck Nardos Tassew, The Janssen Pharmaceutical Companies of Johnson & Johnson Daniella Pizarro, Merck Heather Kowalski, BlueRock Therapeutics Surekha Akella, AbbVie |